Product Name | MF | CAS | Details |
---|
(R)-Metomidate | C13H14N2O2 | 61045-91-8 | Details |
Etomidate EP Impurity A | C12H12N2O2 | 3157-27-5 | Details |
GDC-6036 | C29H32ClF4N7O2 | 2417987-45-0 | Details |
CNX-1351 | C30H35N7O3S | 1276105-89-5 | Details |
BOS318 | C28H32Cl2N6O3 | 2387633-15-8 | Details |
(S)-Remoxipride Hydrochloride | C16H24BrClN2O3 | 73220-03-8 | Details |
RBM013209 | C19H24N6O3 | 2597933-17-8 | Details |
SCH529074 | C31H36Cl2N6 | 922150-11-6 | Details |
BM635 | C25H29FN2O | 1493762-74-5 | Details |
Atopaxar Hydrobromide | C29H38FN3O5 | 751475-53-3 | Details |
NE-100 hydrochloride | C23H33NO2.HCl | 149409-57-4 | Details |
Nomifensine maleate | C16H18N2.C4H4O4 | 32795-47-4 | Details |
Auten-99 HBr | C17H15BrN2S | 1049780-58-6 | Details |
INS3-54A18 | C23H16ClNO2 | 328998-53-4 | Details |
Loreclezole | C10H6Cl3N3 | 117857-45-1 | Details |
Eprotirome | C18H17Br2NO5 | 355129-15-6 | Details |
EB-3D | C30H36BrN4O2+ | 1839150-63-8 | Details |
UPF1069 | C17H13NO3 | 1048371-03-4 | Details |
Y06036 | C16H15BrN2O5S | 1832671-96-1 | Details |
ST034307 | C10H4Cl4O2 | 133406-29-8 | Details |
R-10015 | C20H19ClN6O2 | 2097938-51-5 | Details |
FK-3311 | C15H13F2NO4S | 116686-15-8 | Details |
SAR407899 | C14H16N2O2 | 923359-38-0 | Details |
CGP-53716 | C23H19N5O | 152459-94-4 | Details |
NAcM-OPT | C23H29Cl2N3O | 2089293-61-6 | Details |
ML402 | C14H14ClNO2S | 298684-44-3 | Details |
A 438079 hydrochloride | C13H10Cl3N5 | 899431-18-6 | Details |
CB-7921220 | C14H12N2O2 | 115453-99-1 | Details |
KY1220 | C14H10N4O3S | 292168-79-7 | Details |
BM212 | C23H25Cl2N3 | 146204-42-4 | Details |
MSDC-0602 | C19H17NO5S | 1133819-87-0 | Details |
NITD-349 | C17H20F2N2O | 1473450-62-2 | Details |
MJN110 | C22H21Cl2N3O4 | 1438416-21-7 | Details |
AF40431 | C17H21NO5 | 181125-92-8 | Details |
C-DIM 12 | C23H17ClN2 | 178946-89-9 | Details |
AU1235 | C17H19F3N2O | 1338780-86-1 | Details |
C-215 | C17H17Cl2N3 | 912780-51-9 | Details |
NS 398 | C13H18N2O5S | 123653-11-2 | Details |
ASP7663 | C14H14FNO3 | 1190217-35-6 | Details |
4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-4-oxido-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-, (4S)- | C29H28F4N4O5 | 2991059-71-1 | Details |
2-Pyrazinecarbonitrile, 6-ethyl-3-[[3-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]amino]-5-[(tetrahydro-2H-pyran-4-yl)amino]- | C29H42N8O2 | 2043019-99-2 | Details |
Picotamide | C21H20N4O3 | 32828-81-2 | Details |
PIP-199 | C27H28N4O3 | 622795-76-0 | Details |
GSK3359088 | C29H37ClN6O5 | 1628830-21-6 | Details |
ML67-33 | C18H17Cl2N5 | 1443290-89-8 | Details |
VK-II-36 | C26H26N2O5 | 955371-66-1 | Details |
1-(2-(3-formyl-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate | C29H31N3O4 | 864760-28-1 | Details |
N-Acetyl DeMethyl MeMantine | C13H21NO | 778-09-6 | Details |
Tricyclo[3.3.1.13,7]decan-1-aMine, 3,5,7-triMethyl-, hydrochloride | C13H24ClN | 15210-60-3 | Details |
7-Acetamido-1,3,5-trimethyladamantane | C15H25NO | 15210-64-7 | Details |
9H-Purin-2-amine, 6-chloro-9-[(2R)-2-deoxy-2-fluoro-2-methyl-β-D-erythro-pentofuranosyl]- | C11H13ClFN5O3 | 881881-89-6 | Details |
INDEX NAME NOT YET ASSIGNED | C21H29ClFN5O7 | 2761681-01-8 | Details |
2-Propenoic acid, 3-(2-amino-3-fluorophenyl)-, methyl ester, (2E)- | C10H10FNO2 | 690664-20-1 | Details |
2-Propenamide, N-(2-bromo-6-fluorophenyl)- | C9H7BrFNO | 1695869-28-3 | Details |
Urea, N-(2-broMo-6-fluorophenyl)-N'-[2-Methoxy-5-(trifluoroMethyl)phenyl]- | C15H11BrF4N2O2 | 917389-23-2 | Details |
N-[2-methoxy-5-(trifluoromethyl)phenyl]acetamide | C10H10F3NO2 | 40622-64-8 | Details |
Selexipag Impurity | C25H30N4O2 | 475086-28-3 | Details |
Cariprazine Impurity | C20H29Cl2N3O2 | 1231947-89-9 | Details |
UniPR1331 | C35H48N2O4 | 1809170-59-9 | Details |
ethyl (2R,3R)-3-cyclopropyl-1-methylaziridine-2-carboxylate | 2864383-32-2 | Details |
Methyl (αS,2S)-4-[(1,1-dimethylethoxy)carbonyl]-α-[[(phenylmethoxy)carbonyl]amino]-2-morpholinepropanoate | C21H30N2O7 | 2641824-60-2 | Details |
Letomovir Impurity 13 | C18H14F4N2O4 | 2991059-69-7 | Details |
1H-Indole, 5-bromo-3-[3-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-2,2-dimethylpropyl]-2-iodo- | C29H33BrINOSi | 2641451-43-4 | Details |
Upadacitinib Impurity | C13H12N4O2S | 1201187-46-3 | Details |
SSAA09E1 | C7H9N3S2 | 433212-75-0 | Details |
Difluorinated Curcumin | C28H22F2O6 | 1170354-22-9 | Details |
M-31850 | C28H21N3O4 | 281224-40-6 | Details |
FQ | C14H9FN2O | 190838-76-7 | Details |
Hepln-13 | C17H13BrN2 | 64369-13-7 | Details |
SULFATE-IONOPHORE I | C22H22N4S2 | 37042-63-0 | Details |
NSC 756093 | C20H19NO4 | 1629908-92-4 | Details |
Alrestatin | C14H9NO4 | 51411-04-2 | Details |
raf kinase-IN-1 | C15H8Br2ClNO2 | 220904-99-4 | Details |
ST1237 | 1380593-17-8 | Details |
Resorcinolnaphthalein | C24H14O5 | 41307-63-5 | Details |
1H-Cyclopropa[3,4]cyclopenta[1,2-c]pyrazole-1-acetic acid, 5,5-difluoro-3b,4,4a,5-tetrahydro-3-(trifluoromethyl)-, (3bR,4aS)- | C10H7F5N2O2 | 2189680-65-5 | Details |
Tyrosinase-IN-2 | C8H8N4O2S | 180864-33-9 | Details |
Teriflunomide Impurity | C9H6F3NO3 | 69066-42-8 | Details |
WAY-313356 | C21H16N4OS | 325694-03-9 | Details |
NLRP3/AIM2-IN-2 | C15H15NO3 | 791840-86-3 | Details |
Milnacipran Impurity | C15H21NO2 | 1353644-49-1 | Details |
NA | C25H23N3O7S2 | 2411972-48-8 | Details |
2-(5-(aminomethyl)-1,2,4-oxadiazol-3-yl)-N-((3S,4R)-1,3-dimethylpiperidin-4-yl)-1-(2,2,2-trifluoroethyl)-1H-indol-4-amine hydrochloride | 2865128-45-4 | Details |
2,3-Diazabicyclo[3.1.1]heptane-4-carboxylic acid, methyl ester, (4S)- | C7H12N2O2 | 3034241-21-6 | Details |
1H-Cyclopropa[3,4]cyclopenta[1,2-c]pyrazole-1-acetic acid, 5,5-difluoro-3b,4,4a,5-tetrahydro-3-(trifluoromethyl)-, (3bS,4aR)- | C10H7F5N2O2 | 1620056-83-8 | Details |
CBD3063 | 1281060-70-5 | Details |
CMP-5 HCl | C21H22ClN3 | 2309409-79-6 | Details |
Capadenoson (BAY 68-4986) | C25H18ClN5O2S2 | 544417-40-5 | Details |
3-Oxetanemethanamine, 3-phenyl- | C10H13NO | 497239-45-9 | Details |
TERT-BUTYL 3-(4-(METHOXYCARBONYL)PHENYL)AZETIDINE-1-CARBOXYLATE | C16H21NO4 | 1240970-70-0 | Details |
trans-3-(benzyloxy)cyclobutanol | C11H14O2 | 1383813-54-4 | Details |
3-fluoroazetidine-1-sulfonyl chloride | C3H5ClFNO2S | 1411940-38-9 | Details |
GSK3008348 | C29H37N5O2 | 1629249-33-7 | Details |
PDD 00017273 | C23H26N6O4S2 | 1945950-21-9 | Details |
MV1035 | C14H14N2OS | 1199944-04-1 | Details |
Alexidine dihydrochloride | C26H58Cl2N10 | 1715-30-6 | Details |
GSK-7975A | C18H12F5N3O2 | 1253186-56-9 | Details |
ZM 447439 | C29H31N5O4 | 331771-20-1 | Details |
BI-78D3 | C13H9N5O5S2 | 883065-90-5 | Details |
Eltanexor(KPT-8602) | C17H10F6N6O | 1642300-52-4 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 |